Safety Assessment for Sotalol Protocol in Outpatient Unit
Condition(s):Supraventricular Arrhythmia; Ventricular Arrythmia; Proarrhythmia; Antiarrhythmic Drug Adverse ReactionLast Updated:July 11, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Supraventricular Arrhythmia; Ventricular Arrythmia; Proarrhythmia; Antiarrhythmic Drug Adverse ReactionLast Updated:July 11, 2022Recruiting
Condition(s):Arrhythmias, Cardiac; Atrial FibrillationLast Updated:January 14, 2022Unknown status
Condition(s):BioequivalenceLast Updated:June 7, 2019Completed
Condition(s):Atrial ArrhythmiaLast Updated:September 26, 2023Completed
Condition(s):ArrhythmiaLast Updated:March 29, 2019Unknown status
Condition(s):HypertensionLast Updated:July 19, 2023Active, not recruiting
Condition(s):Long QT Syndrome; Drug ToxicityLast Updated:April 4, 2022Unknown status
Condition(s):Atrial FibrillationLast Updated:January 9, 2024Completed
Condition(s):Atrial FibrillationLast Updated:November 29, 2023Recruiting
Condition(s):Ventricular Tachycardia; Coronary Artery DiseaseLast Updated:January 27, 2015Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.